LeafNLP Demos
Back to explore

Report #2870643

Received Nov 5, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Migraine

Symptom narrative

already suffer from migraines; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of migraine in a patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced migraine (Verbatim: already suffer from migraines). The outcome of the migraine was not reported. It was unknown if the reporter considered the migraine to be related to Arexvy. It was unknown if the company considered the migraine to be related to Arexvy. Additional Information: GSK Receipt Date: 22-OCT-2025 This case was reported by a patient via interactive digital media. The batch number was not provided and unable to contact the reporter.